Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.023
+0.003 (0.10%)
At close: Oct 7, 2025, 4:00 PM EDT
3.050
+0.027 (0.89%)
After-hours: Oct 7, 2025, 5:58 PM EDT

Grace Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
4231322154120
Upgrade
Market Cap Growth
48.30%-2.84%56.90%-62.03%-55.00%250.73%
Upgrade
Enterprise Value
22207-10892
Upgrade
Last Close Price
3.022.283.422.767.3228.80
Upgrade
PS Ratio
-----612.61
Upgrade
PB Ratio
0.660.470.520.300.502.16
Upgrade
P/TBV Ratio
2.921.812.581.102.122.16
Upgrade
EV/Sales Ratio
-----470.71
Upgrade
Debt / Equity Ratio
---0.010.000.00
Upgrade
Asset Turnover
-----0.01
Upgrade
Quick Ratio
8.6511.5314.098.4113.5638.80
Upgrade
Current Ratio
8.8711.7714.268.5913.8939.50
Upgrade
Return on Equity (ROE)
-16.78%-14.91%-19.82%-48.15%-11.98%-57.33%
Upgrade
Return on Assets (ROA)
-13.26%-14.35%-9.25%-10.96%-7.94%-15.70%
Upgrade
Return on Capital (ROIC)
-15.05%-16.24%-10.83%-12.86%-9.23%-19.45%
Upgrade
Earnings Yield
-24.69%-30.59%-39.92%-206.80%-18.17%-16.39%
Upgrade
FCF Yield
-31.39%-47.65%-38.38%-77.64%-31.90%-11.98%
Upgrade
Buyback Yield / Dilution
-28.20%-26.85%-28.16%-21.09%-148.46%-40.25%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q